| CAS No.: | 2156-56-1 |
|---|---|
| Formula: | C2HCl2nao2 |
| EINECS: | 218-461-3 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Colour: | White |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
|
Product Name
|
Sodium dichloroacetate |
|
Category
|
Plant Extracts
|
|
Analysis
|
HPLC
|
|
Storage
|
Keep in cool and dry place, well-closed, away from moisture or direct sunlight.
|
Sodium Dichloroacetate DCA
Other name:Acetic acid, 2,2-dichloro-, sodium s
1.CAS:2156-56-1
2.Purity: 99%
3.MF:C2HCl2NaO2
4.EINECS:218-461-3
Sodium Dichloroacetate DCA, commonly referred to simply as dichloroacetate or DCA, is a buffered form of dichloracetic acid. This synthetic chemical compound has gained attention because it shows some potential as a cancer treatment. The buffered form of dichloracetic acid is not an acid and can be taken by mouth without causing burning. Sodium dichloroacetate is not approved drug and so is not readily available as a pharmaceutical-grade product. Consult with your doctor if you are interested in this potential treatment, which is still in the early research stages.
Sodium dichloroacetate (DCA) is a compound that has been studied for its potential use in the treatment of cancer and other medical conditions. Its function is to inhibit the activity of an enzyme called pyruvate dehydrogenase kinase, which can help to shift the metabolism of cells from anaerobic (without oxygen) to aerobic (with oxygen) metabolism. Here are some of the common applications of Sodium Dichloroacetate:
Cancer treatment: DCA has been studied for its potential use in the treatment of cancer. Some studies have suggested that DCA may have anticancer effects, as cancer cells tend to rely more heavily on anaerobic metabolism than normal cells. By shifting the metabolism of cancer cells toward aerobic metabolism, DCA may be able to inhibit the growth and spread of cancer cells. However, more research is needed to determine the safety and effectiveness of DCA in cancer treatment.
Mitochondrial diseases: DCA has been studied for its potential use in treating mitochondrial diseases, a group of genetic disorders that affect the function of the mitochondria, which are the energy-producing structures in cells. DCA may help to improve mitochondrial function and reduce symptoms of mitochondrial diseases, but more research is needed to determine its safety and effectiveness for these conditions.
Metabolic disorders: DCA has also been studied for its potential use in treating metabolic disorders, such as diabetes and obesity. It may help to reduce inflammation, which are associated with these conditions.
Neurological conditions: DCA has been studied for its potential use in treating neurological conditions, such as Alzheimer's disease and Parkinson's disease. It may help to improve mitochondrial function and reduce inflammation in the brain, which are associated with these conditions.
It is important to note that DCA is not approved by the U.S. Food and Drug Administration (FDA) for any medical use, and its use outside of clinical trials is not recommended. DCA can cause serious side effects, including liver damage, nerve damage, and changes in blood chemistry. It should only be used under the supervision of a healthcare provider who is experienced in its use.
In summary, Sodium dichloroacetate (DCA) is primarily studied for its potential use in the treatment of cancer and other medical conditions. Its common applications include the treatment of cancer, mitochondrial diseases, metabolic disorders, and neurological conditions. However, more research is needed to determine the safety and effectiveness of DCA for these applications. Its use should only be under the supervision of a healthcare provider who is experienced in its use.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}